Universal Display Corporation has acquired Adesis, a contract research organization (CRO) with 43 employees specializing in organic and organometallic synthetic research, development and commercialization, for $36 million. Adesis is a critical technology vendor to companies in the pharmaceutical, fine chemical, biomaterials, and catalyst industries, and has worked with Universal Display over the last few years to help advance and accelerate a number of Universal Display’s product offerings. “...